Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

Merck MK1084-012

Study Phase: Phase III

Condition(s): Metastatic Colorectal Cancer, KRAS G12C-mutant
A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

ClinicalTrials.gov NCT ID: NCT06997497

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_vivian-colon

Vivian Colon

Primary Contact - Study Coordinator

484-658-1793
vivian.colon@sluhn.org

Arturo Loaiza-Bonilla, MD

Arturo Loaiza-Bonilla, MD

Physician - Principal Investigator

NRG - NRG-CC005 - (FORTE)

Study Phase: Observational - Screening

Condition(s): Non-advanced polyps
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

ClinicalTrials.gov NCT ID: NCT05080673

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_vivian-colon

Vivian Colon

Primary Contact - Study Coordinator

484-658-1793
vivian.colon@sluhn.org

profile_kimberly-chaput

Kimberly J. Chaput, DO

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today